SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-19-011164
Filing Date
2019-02-27
Accepted
2019-02-27 17:16:02
Documents
3
Period of Report
2019-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A a19-5477_28ka.htm 8-K/A 24646
2 EX-99.1 a19-5477_2ex99d1.htm EX-99.1 212527
3 GRAPHIC g54772mm01i001.jpg GRAPHIC 4890
  Complete submission text file 0001104659-19-011164.txt   245343
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37368 | Film No.: 19638843
SIC: 2836 Biological Products, (No Diagnostic Substances)